14th Annual BIO Investor Forum to Celebrate Fierce 15 Winners amid Rising Investor Interest in Biotechnology August 12, 2015, 09:21

«The BIO Investor Forum is the perfect venue for investors to connect with executives at the top fast-growing life sciences companies," said Jim Greenwood, President & CEO, BIO. «The environment for biotech is strong right now — there has never been a better time for emerging companies to seek new funding sources.»

This year’s program will include business and therapeutic panels, company presentations and fireside chats with respected industry veterans discussing the latest trends in biotech. The event will celebrate winners of the Fierce 15 contest at the opening reception, and feature a panel of past winners discussing their experiences with investor management.

The first Fireside Chat will feature Robert T. Nelsen, Co-Founder and Managing Director, ARCH Venture Partners.

Therapeutic Panel Topics:

Report from the Frontier: Emerging Oncology Trends Bridging ASCO to ASH
Precision Medicine: Leveraging National Genomic Databases for Therapy Development (US, UK, Iceland)
Stretching Your Dollar: Methods and Tools for Increasing the Productivity of Clinical Trials
Policy Outlook-Valuation Model Implications of 21st Century Cures, IP Reform, TPP, and PDUFA VI
Business Panel Topics

Investor Management Lessons of Fierce 15 Alumni CEOs
Venture Capital Funding Trends: BIO Analysis of Ten Years of Investment and the Gaps that Appear
BioCentury Presents: Courting Crossover Investors
2015–16 Market Outlook-Status of the IPO Appetite, M&A, Foreign Shocks, and Higher Interest Rates?
Nominations are now open for the Buzz of BIO contest at the 2015 BIO Investor Forum. The Buzz of BIO contest recognizes highly innovative companies in the biotech sector and helps position these companies to develop strategic partnerships within the industry. Ten biotechs will be nominated in each of two categories — Early Stage Entrepreneurs and Late Stage Leaders. Nominations must be received by August 18; winners will then be chosen by online vote beginning August 24.

Company Presentations: The conference features presentations by more than 100 biotech companies poised to join the growth «watch list» in 2016, as well as a number of nonprofit and venture philanthropy organizations. More information about company presentations can be found here.

Investor Presence: The 2015 BIO Investor Forum will assemble public and venture-stage growth companies, as well as top public and private equity investors, to explore investment trends and opportunities in life sciences. To view the list of current investment community participants, please visit here.

BIO One-on-One Partnering™: Partnering provides investors and business development professionals with an opportunity to arrange meetings with licensing and therapeutic franchise heads. Partnering will open in early September and will be accessible here.

Event Information: To learn more about the BIO Investor Forum, including registration, program and partnering information, please visit this link.

Media Registration: Media registration is now open and can be accessed here.

About BIO

BIO is the world’s largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIO produces BIOtechNOW, an online portal and monthly newsletter chronicling «innovations transforming our world." Subscribe to BIOtechNOW.

http://finance.yahoo.com/news/14th-annual-bio-investor-forum-143800673.html;_ylt=AwrC0CM2JspVRzAA162TmYlQ;_ylu=X3oDMTByMHVzM20zBGNvbG8DYmYxBHBvcwMzBHZ0aWQDBHNlYwNzYw-